or Try an Advanced Search...

    Technical Analysis for AUTL - Autolus Therapeutics plc

    Grade Last Price % Change Price Change
    F 4.39 7.86% 0.32
    AUTL closed up 7.86 percent on Friday, May 17, 2024, on 1.26 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical AUTL trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Shooting Star Candlestick Bearish 0.00%
    Lizard Bearish Bearish Day Trade Setup 0.00%
    Crossed Above 20 DMA Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze + Upper Band Touch Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    20 DMA Resistance Bearish 7.86%
    Older End-of-Day Signals for AUTL ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Resistance 2 days ago
    Upper Bollinger Band Resistance 2 days ago
    2x Volume Pace 2 days ago
    1.5x Volume Pace 2 days ago
    3x Volume Pace 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AUTL Chart by TradingView
    Basic chart:

    Profile

    Autolus Therapeutics Ltd is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and AUTO6.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Treatment Of Cancer

    Is AUTL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 18 Q1 2024 Autolus Therapeutics PLC Earnings Call
    May 17 Autolus Therapeutics plc (AUTL) Q1 2024 Earnings Call Transcript
    May 17 Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
    May 17 Autolus Therapeutics GAAP EPS of -$0.24 misses by $0.09, revenue of $10.09M misses by $14.96M
    May 17 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
    May 14 Autolus Therapeutics: Trading Like Their Products Are Not Valuable, Which Is An Opportunity
    May 14 Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
    May 13 Autolus Therapeutics Q1 2024 Earnings Preview
    May 13 Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
    Apr 25 Recent 13% pullback isn't enough to hurt long-term Autolus Therapeutics (NASDAQ:AUTL) shareholders, they're still up 157% over 1 year
    See more AUTL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.45
    52 Week Low 2.01
    Average Volume 1,610,960
    200-Day Moving Average 4.50
    50-Day Moving Average 5.00
    20-Day Moving Average 4.09
    10-Day Moving Average 4.07
    Average True Range 0.33
    RSI (14) 50.00
    ADX 21.68
    +DI 28.20
    -DI 18.92
    Chandelier Exit (Long, 3 ATRs) 4.26
    Chandelier Exit (Short, 3 ATRs) 4.60
    Upper Bollinger Bands 4.50
    Lower Bollinger Band 3.68
    Percent B (%b) 0.87
    BandWidth 20.01
    MACD Line -0.24
    MACD Signal Line -0.33
    MACD Histogram 0.0824
    Fundamentals Value
    Market Cap 763.81 Million
    Num Shares 174 Million
    EPS -0.98
    Price-to-Earnings (P/E) Ratio -4.48
    Price-to-Sales 200.99
    Price-to-Book 6.15
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.07
    Resistance 3 (R3) 5.14 4.99 4.95
    Resistance 2 (R2) 4.99 4.82 4.95 4.91
    Resistance 1 (R1) 4.69 4.71 4.62 4.62 4.88
    Pivot Point 4.54 4.54 4.50 4.50 4.54
    Support 1 (S1) 4.24 4.37 4.17 4.17 3.90
    Support 2 (S2) 4.09 4.26 4.05 3.87
    Support 3 (S3) 3.79 4.09 3.83
    Support 4 (S4) 3.72